1[1]Fisher B, Anderson S, Redmond CK, et al. Reanalysis and results after 12 years of follow - up in a randomized clinical trial comparing total mastectomy with lumpectomy with or without irradiation in the treatment of breast cancer [see comments][J]. N Engl J Med, 1995,333(22): 1456 - 61.
2[2]Veronesi U, Salvadori B, Luini A, et al. Breast conservation is a safe method in patients with small cancer of the breast. Long - term results of three randomised trials on 1,973 patients [see comments][J]. Eur J Cancer, 1995 , 31A(10): 1574-9.
3[3]Harris J, Levene M, Svensson G, et al. Analysis of cosmetic results following primary radiation therapy to stage Ⅰ and Ⅱ carcinoma of breast[J]. Int J Radiat Oncol Biol Rhvs, 1979, 5: 257.
4[4]Veronesi U, Luini A, Galimberti V, et al. Conservation approaches for the management of stage Ⅰ/Ⅱ carcinoma of the breast: Milan Cancer Institute trials[J]. World J Surg. 1994, 18(1): 70-5.
5[5]Mills JM, Schultz DJ, Solin LJ. Preservation of cosmesis with lowcomplication risk after conservative surgery and radiotherapy for ductal carcinoma in situ of the breast[J]. Int J Radiat Oncol Biol Phys,1997, 39(3): 637-41.
6[6]Nixon AJ, Neuberg D, Hayes DF, et al. Relationship of patient age to pathologic features of the tumor and prognosis for patients with stage Ⅰ or Ⅱ breast cancer[J]. J Clin Oncol. 1994 , 12(5): 888-94.
7[7]Chabner E, Nixon A, Gelman R , et al. Family history and treatment outcome in young women after breast - conserving surgery and radiation therapy for early-stage breast cancer[J ]. J Clin Oncol. 1998 , 16(6): 2045 - 51.
8[8]Ford D, Easton DF, Bishop DT, et al. Risks of cancer in BRCA1mutation carriers. Breast Cancer Linkage Consortium [ J ]. Lancet.1994 , 343(8899): 692-5.
9[9]Scully R, Chen J, Plug A, et al. Association of BRCA1 with Rad51in mitotic and meiotic cells[J]. Cell. 1997 , 88(2): 265-75.
10[10]Marcus JN, Watson P, Page DL, et al. Hereditary breast cancer pathobiology prognosis, and BRCA1 and BRCA2 gene linkage [J].Cancer, 1996,77:697.
